Evidence map›Paper›PMID 37457719›Full record

ArticleFrontiers in immunology2023

Maximizing utility of nondirected living liver donor grafts using machine learning.

Kiran Bambha, Nicole J Kim, Mark Sturdevant, James D Perkins, Catherine Kling, Ramasamy Bakthavatsalam, Patrick Healey, Andre Dick, Jorge D Reyes, Scott W Biggins

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Emerging applications of traditional and generative artificial intelligence in liver transplantation.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Article
  2. Review
  3. Consequences of low estimated glomerular filtration rate either before or early after kidney donation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kiran BambhaDivision of Gastroenterology and Hepatology, Department of Medicine, University of Washington, Seattle, WA, United States.
Nicole J KimDivision of Gastroenterology and Hepatology, Department of Medicine, University of Washington, Seattle, WA, United States.
Mark SturdevantClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
James D PerkinsClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Catherine KlingClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Ramasamy BakthavatsalamClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Patrick HealeyClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Andre DickClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Jorge D ReyesClinical and Bio-Analytics Transplant Laboratory (C-BATL), University of Washington, Seattle, WA, United States.
Scott W BigginsDivision of Gastroenterology and Hepatology, Department of Medicine, University of Washington, Seattle, WA, United States.

Funding

UNIVERSITY OF WASHINGTON GI TRAINING GRANTT32DK007742 · NIDDK · UNIVERSITY OF WASHINGTON · PI GRADY, WILLIAM MALLORY · 1996 to 2022
$4.7M
NIDDK NIH HHS T32 DK007742
6 · The paper itself

Abstract

Objective: There is an unmet need for optimizing hepatic allograft allocation from nondirected living liver donors (ND-LLD). Materials and method: Using OPTN living donor liver transplant (LDLT) data (1/1/2000-12/31/2019), we identified 6328 LDLTs (4621 right, 644 left, 1063 left-lateral grafts). Random forest survival models were constructed to predict 10-year graft survival for each of the 3 graft types. Results: Donor-to-recipient body surface area ratio was an important predictor in all 3 models. Other predictors in all 3 models were: malignant diagnosis, medical location at LDLT (inpatient/ICU), and moderate ascites. Biliary atresia was important in left and left-lateral graft models. Re-transplant was important in right graft models. C-index for 10-year graft survival predictions for the 3 models were: 0.70 (left-lateral); 0.63 (left); 0.61 (right). Similar C-indices were found for 1-, 3-, and 5-year graft survivals. Comparison of model predictions to actual 10-year graft survivals demonstrated that the predicted upper quartile survival group in each model had significantly better actual 10-year graft survival compared to the lower quartiles (p<0.005). Conclusion: When applied in clinical context, our models assist with the identification and stratification of potential recipients for hepatic grafts from ND-LLD based on predicted graft survivals, while accounting for complex donor-recipient interactions. These analyses highlight the unmet need for granular data collection and machine learning modeling to identify potential recipients who have the best predicted transplant outcomes with ND-LLD grafts.

Indexed as

Liver FailureLiver TransplantationHumansLiving DonorsRetrospective Studiesallocationallograftaltruisticanonymousartificial intelligenceliver transplantliving donation

Identifiers

PMID37457719
PMCPMC10344453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.